Johnson Investment Counsel’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.21M | Buy |
20,835
+45
| +0.2% | +$4.78K | 0.02% | 281 |
|
|
2025
Q1 | $2.58M | Buy |
20,790
+1,000
| +5% | +$124K | 0.02% | 240 |
|
|
2024
Q4 | $2.44M | Sell |
19,790
-1,100
| -5% | -$135K | 0.02% | 244 |
|
|
2024
Q3 | $2.33M | Buy |
20,890
+160
| +0.8% | +$17.8K | 0.02% | 256 |
|
|
2024
Q2 | $2.21M | Buy |
20,730
+3,890
| +23% | +$415K | 0.02% | 254 |
|
|
2024
Q1 | $2.03M | Buy |
16,840
+4,444
| +36% | +$535K | 0.02% | 271 |
|
|
2023
Q4 | $1.52M | Sell |
12,396
-700
| -5% | -$86.1K | 0.02% | 303 |
|
|
2023
Q3 | $1.7M | Buy |
13,096
+110
| +0.8% | +$14.2K | 0.02% | 273 |
|
|
2023
Q2 | $1.61M | Buy |
12,986
+2,646
| +26% | +$328K | 0.02% | 283 |
|
|
2023
Q1 | $1.51M | Buy |
+10,340
| New | +$1.51M | 0.02% | 283 |
|